ConvaTec Financial Statements From 2010 to 2024

CNVVF Stock  USD 2.95  0.10  3.51%   
ConvaTec Group financial statements provide useful quarterly and yearly information to potential ConvaTec Group Plc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ConvaTec Group financial statements helps investors assess ConvaTec Group's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ConvaTec Group's valuation are summarized below:
ConvaTec Group Plc does not presently have any fundamental signals for analysis.
Check ConvaTec Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ConvaTec Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . ConvaTec financial statements analysis is a perfect complement when working with ConvaTec Group Valuation or Volatility modules.
  
This module can also supplement various ConvaTec Group Technical models . Check out the analysis of ConvaTec Group Correlation against competitors.

ConvaTec Group Plc Company Operating Margin Analysis

ConvaTec Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current ConvaTec Group Operating Margin

    
  0.10 %  
Most of ConvaTec Group's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ConvaTec Group Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, ConvaTec Group Plc has an Operating Margin of 0.1015%. This is 100.29% lower than that of the Healthcare sector and 102.16% lower than that of the Medical Instruments & Supplies industry. The operating margin for all United States stocks is 101.84% lower than that of the firm.

ConvaTec Group Plc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ConvaTec Group's current stock value. Our valuation model uses many indicators to compare ConvaTec Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ConvaTec Group competition to find correlations between indicators driving ConvaTec Group's intrinsic value. More Info.
ConvaTec Group Plc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ConvaTec Group Plc is roughly  1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ConvaTec Group's earnings, one of the primary drivers of an investment's value.

About ConvaTec Group Financial Statements

ConvaTec Group stakeholders use historical fundamental indicators, such as ConvaTec Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although ConvaTec Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in ConvaTec Group's assets and liabilities are reflected in the revenues and expenses on ConvaTec Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ConvaTec Group Plc. Please read more on our technical analysis and fundamental analysis pages.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. Convatec Group operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10142 people.

Currently Active Assets on Macroaxis

Other Information on Investing in ConvaTec Pink Sheet

ConvaTec Group financial ratios help investors to determine whether ConvaTec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.